In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease
(NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important …

Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

The rising global prevalence of metabolic diseases has increased the prevalence of non-
alcoholic fatty liver disease (NAFLD), leading to an increase in cases of NAFLD-related …

Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …

Obesity is recognised as a risk factor for many types of cancers, in particular hepatocellular
carcinoma (HCC). A critical factor in the development of HCC from non-alcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD), including its more severe manifestation,
nonalcoholic steatohepatitis (NASH), has a global prevalence of 20–25% and is a major …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder
worldwide, affecting 25.2% of the general population. In fact, NAFLD is among the most …

Hepatocellular carcinoma (HCC) is estimated to be the third leading cause of cancer-related
mortality and is characterized by low survival rates. Nonalcoholic fatty liver disease (NAFLD) …

The term nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of increasingly
harmful conditions ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic …

Simple Summary Metabolic-dysfunction-associated steatotic liver disease (previously known
as non-alcoholic fatty liver disease) is a term for a range of liver conditions in which excess …